Health Care & Life Sciences » Pharmaceuticals | Yantai Dongcheng Biochemicals Co. Ltd.

Yantai Dongcheng Biochemicals Co. Ltd. | Balance Sheet

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
296
304
520
936
805
1,231
Total Accounts Receivable
204
221
401
571
697
1,007
Inventories
215
292
353
426
575
604
Other Current Assets
11
11
13
8
5
26
Total Current Assets
726
828
1,287
1,941
2,082
2,869
Net Property, Plant & Equipment
329
376
436
614
651
972
Total Investments and Advances
-
10
10
51
866
82
Long-Term Note Receivable
-
-
7
6
6
10
Intangible Assets
192
201
817
1,635
1,635
2,941
Other Assets
-
-
1
4
4
43
Total Assets
1,252
1,419
2,566
4,268
5,273
6,967
ST Debt & Current Portion LT Debt
48
111
152
715
701
Accounts Payable
27
39
46
54
66
Income Tax Payable
7
4
9
23
18
Other Current Liabilities
58
70
88
328
494
Total Current Liabilities
139
224
296
1,120
1,281
Long-Term Debt
-
-
-
-
624
Deferred Taxes
4
3
8
6
17
Other Liabilities
11
-
2
2
2
Total Liabilities
150
225
299
1,134
1,919
Common Equity (Total)
1,088
1,169
2,048
2,768
2,903
Total Shareholders' Equity
1,088
1,169
2,048
2,768
2,903
Total Equity
1,101
1,184
2,236
3,084
3,289
Liabilities & Shareholders' Equity
1,252
1,419
2,566
4,268
5,273
Accumulated Minority Interest
14
15
188
316
386
Non-Equity Reserves
-
11
30
50
65

About Yantai Dongcheng Biochemicals Co.

View Profile
Address
No. 7 Changbaishan Road
Yantai Shandong 264006
China
Employees -
Website http://www.dcb-group.com
Updated 07/08/2019
Yantai Dongcheng Biochemicals Co., Ltd. engages in the research and development, production, and marketing of biochemical active pharmaceutical ingredient (API). It involves in API, chemical synthetic drugs, and modern chinese medicines. The firm's products include heparin series, chondroitin sulphate, marine collagen, hyaluronic acid, glucosamine series, heparinoid, and cytochrome C.